ArticleSignal transduction and targeted therapy

A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer.

Weidong Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.